Inoue Y, Noda K
Dept. of Oby. & Gyn. School of Med. Kinki Univ.
Gan No Rinsho. 1989 Oct;35(13):1610-4.
The prognosis of 589 patients with adenocarcinoma, 387 with mixed type of adenocarcinoma and squamous cell carcinoma of the uterine cervix from 18 hospitals in Japan were evaluated. Stage 0, I a patients with adenocarcinoma or mixed type had good survival. Stage I b, II, III patients had smaller five-year survival (p less than 0.01) than squamous cell carcinoma. Lymph nodes metastasis was related to poorer survival. Radiation therapy or chemotherapy was not sufficient for patients with stage I b, II, III, IV diseases.
对来自日本18家医院的589例子宫颈腺癌患者、387例子宫颈腺癌与鳞状细胞癌混合型患者的预后进行了评估。0期、Ⅰa期的腺癌或混合型患者生存率良好。Ⅰb期、Ⅱ期、Ⅲ期患者的五年生存率低于鳞状细胞癌(p<0.01)。淋巴结转移与较差的生存率相关。放射治疗或化疗对Ⅰb期、Ⅱ期、Ⅲ期、Ⅳ期疾病患者来说并不充分。